Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-009051

Chief Commercial Officer, SaaS sold 9,745 shares at $239.31 ($2,332,096)

  • Chief Commercial Officer, SaaS acquired 9,745 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ghoshal Kaushik · Chief Commercial Officer, SaaS

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-10 Exercise or conversion : show line 1 in the form 10b5-1 +169 $146.34 $24,731 9,894 D
2025-03-10 Exercise or conversion : show line 2 in the form 10b5-1 +105 $211.76 $22,235 9,999 D
2025-03-10 Exercise or conversion : show line 3 in the form 10b5-1 +3,589 $146.34 $525,214 13,588 D
2025-03-10 Exercise or conversion : show line 4 in the form 10b5-1 +5,882 $211.76 $1,245,572 19,470 D
2025-03-10 Sale : show line 5 in the form 10b5-1 −9,745 $239.31 $2,332,096 9,725 D
Open-market sales · 9,745 sh · avg $239.31 · $2,332,096

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-03-10 Exercise or conversion : show line 6 in the form 10b5-1 ResMed Common Stock Options −169 0 D
2025-03-10 Exercise or conversion : show line 7 in the form 10b5-1 ResMed Common Stock Options −105 0 D
2025-03-10 Exercise or conversion : show line 8 in the form 10b5-1 ResMed Common Stock Options −5,882 0 D
2025-03-10 Exercise or conversion : show line 9 in the form 10b5-1 ResMed Common Stock Options −3,589 0 D
Loading xslF345X05/form4.xml…